Φορτώνει......
Long-Term Immunogenicity of Live Oral Cholera Vaccine CVD 103-HgR in Adolescents Aged 12–17 Years in the United States
As part of a phase 4, randomized, double-blind, placebo-controlled trial to assess the immunogenicity and safety of PXVX0200 in children and adolescents aged 2–17 years, a subset of 73 adolescent subjects aged 12–17 years was followed for 2 years after vaccination and had blood collected for antibod...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Am J Trop Med Hyg |
|---|---|
| Κύριοι συγγραφείς: | , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
The American Society of Tropical Medicine and Hygiene
2021
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8103473/ https://ncbi.nlm.nih.gov/pubmed/33819178 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4269/ajtmh.20-1576 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|